Global Losartan Market, By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026

Global losartan market was valued at USD4.73 billion in 2020 and is expected to grow at a formidable rate of 7.81% during the forecast period. The global losartan market is driven by the growing prevalence of hypertension, stroke and diabetic nephropathy across the world. Losartan is a medication that is used to treat high blood pressure. Furthermore, losartan is widely used in slowing down long-term kidney damage due to type II diabetes which is further expected to propel the market growth through 2026. The sudden outbreak and spread of the COVID-19 pandemic has resulted in the loss of jobs for many people due to which the level of anxiety and hypertension has increased among the people. This has, in turn, increased the demand for losartan, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies are working on manufacturing in-house losartan tablets which are expected to create lucrative opportunities for the market growth over the next few years.

The global losartan market is segmented based on source, form, strength, distribution channel, application, end-user, company and region. Based on source, the market can be split into contract manufacturing organizations and in-house. Among these, the in-house segment is expected to witness the fastest growth due to increased preference for in-house manufacturing by key market players as the company can have full control over the quality and the quantity of the products. Based on form, the market can be fragmented into tablets and powder. Here, the tablet segment is dominating the market with a market share of nearly 87% and is expected to maintain its position in the forecast years as well. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years.

Regionally, the global losartan market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate in the overall losartan market owing to the well-established healthcare infrastructure and presence of major pharmaceutical and biotechnology giants in the region. However, Asia-Pacific is expected to witness robust growth in the market owing to the presence of a large pool of patients suffering from various life-threatening conditions in economies such as China and India.

Major players operating in the global losartan market include Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddys Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 20222026

Objective of the Study:
To analyze the historical growth in the market size of the global losartan market from 2016 to 2020.
To estimate and forecast the market size of the global losartan market from 2021 to 2026 and growth rate until 2026.
To classify and forecast the global losartan market based on source, form, strength, distribution channel, application, end-user, company and regional distribution.
To identify dominant region or segment in the global losartan market.
To identify drivers and challenges for global losartan market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global losartan market.
To identify and analyze the profile of leading players operating in global losartan market.
To identify key sustainable strategies adopted by market players in global losartan market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global Losartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
Losartan manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to losartan kit
Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, global losartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Losartan Market, By Source:
o Contract Manufacturing Organizations
o In-House
Global Losartan Market, By Form:
o Tablet
o Powder
Global Losartan Market, By Strength:
o 25 mg
o 50 mg
o 100 mg
o Others
Global Losartan Market, By Distribution Channel:
o Offline
o Online
Global Losartan Market, By Application:
o Hypertension
o Stroke
o Diabetic nephropathy
o Others
Global Losartan Market, By End-User:
o Adult
o Pediatric
Global Losartan Market, By Region:
o North America
United States
Canada
Mexico
o Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Poland
o Asia-Pacific
China
Japan
India
Australia
South Korea
Hong Kong
Philippines
Malaysia
Indonesia
Vietnam
Thailand
o South America
Brazil
Argentina
Colombia
Chile
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
Nigeria
Kenya
Algeria
Ethiopia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the global losartan market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a companys specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on Global Losartan Market
4.Executive Summary
5.Voice of Customer
6.Global Losartan Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value & Volume
6.2.Market Share & Forecast
6.2.1.By Source (Contract Manufacturing Organizations, In-House)
6.2.2.By Form (Tablet, Powder)
6.2.3.By Strength (25 mg, 50 mg, 100 mg, Others)
6.2.4.By Distribution Channel (Offline, Online)
6.2.5.By Application (Hypertension, Stroke, Diabetic nephropathy, Others)
6.2.6.By End-User (Adult, Pediatric)
6.2.7.By Company (2020)
6.2.8.By Region
6.3.Product Market Map
7.North America Losartan Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Source
7.2.2.By Form
7.2.3.By Strength
7.2.4.By Distribution Channel
7.2.5.By Application
7.2.6.By End-User
7.2.7.By Country
7.3.North America: Country Analysis
7.3.1.United States Losartan Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.By Source
7.3.1.2.2.By Form
7.3.1.2.3.By Strength
7.3.1.2.4.By Distribution Channel
7.3.1.2.5.By Application
7.3.1.2.6.By End-User
7.3.2.Canada Losartan Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.By Source
7.3.2.2.2.By Form
7.3.2.2.3.By Strength
7.3.2.2.4.By Distribution Channel
7.3.2.2.5.By Application
7.3.2.2.6.By End-User
7.3.3.Mexico Losartan Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.By Source
7.3.3.2.2.By Form
7.3.3.2.3.By Strength
7.3.3.2.4.By Distribution Channel
7.3.3.2.5.By Application
7.3.3.2.6.By End-User
8.Europe Losartan Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Source
8.2.2.By Form
8.2.3.By Strength
8.2.4.By Distribution Channel
8.2.5.By Application
8.2.6.By End-User
8.2.7.By Country
8.3.Europe: Country Analysis
8.3.1.Germany Losartan Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Source
8.3.1.2.2.By Form
8.3.1.2.3.By Strength
8.3.1.2.4.By Distribution Channel
8.3.1.2.5.By Application
8.3.1.2.6.By End-User
8.3.2.France Losartan Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Source
8.3.2.2.2.By Form
8.3.2.2.3.By Strength
8.3.2.2.4.By Distribution Channel
8.3.2.2.5.By Application
8.3.2.2.6.By End-User
8.3.3.United Kingdom Losartan Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Source
8.3.3.2.2.By Form
8.3.3.2.3.By Strength
8.3.3.2.4.By Distribution Channel
8.3.3.2.5.By Application
8.3.3.2.6.By End-User
8.3.4.Italy Losartan Market Outlook
8.3.4.1.Market Size & Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share & Forecast
8.3.4.2.1.By Source
8.3.4.2.2.By Form
8.3.4.2.3.By Strength
8.3.4.2.4.By Distribution Channel
8.3.4.2.5.By Application
8.3.4.2.6.By End-User
8.3.5.Spain Losartan Market Outlook
8.3.5.1.Market Size & Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share & Forecast
8.3.5.2.1.By Source
8.3.5.2.2.By Form
8.3.5.2.3.By Strength
8.3.5.2.4.By Distribution Channel
8.3.5.2.5.By Application
8.3.5.2.6.By End-User
8.3.6.Russia Losartan Market Outlook
8.3.6.1.Market Size & Forecast
8.3.6.1.1.By Value
8.3.6.2.Market Share & Forecast
8.3.6.2.1.By Source
8.3.6.2.2.By Form
8.3.6.2.3.By Strength
8.3.6.2.4.By Distribution Channel
8.3.6.2.5.By Application
8.3.6.2.6.By End-User
8.3.7.Poland Losartan Market Outlook
8.3.7.1.Market Size & Forecast
8.3.7.1.1.By Value
8.3.7.2.Market Share & Forecast
8.3.7.2.1.By Source
8.3.7.2.2.By Form
8.3.7.2.3.By Strength
8.3.7.2.4.By Distribution Channel
8.3.7.2.5.By Application
8.3.7.2.6.By End-User
9.Asia-Pacific Losartan Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Source
9.2.2.By Form
9.2.3.By Strength
9.2.4.By Distribution Channel
9.2.5.By Application
9.2.6.By End-User
9.2.7.By Country
9.3.Asia-Pacific: Country Analysis
9.3.1.China Losartan Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Source
9.3.1.2.2.By Form
9.3.1.2.3.By Strength
9.3.1.2.4.By Distribution Channel
9.3.1.2.5.By Application
9.3.1.2.6.By End-User
9.3.2.Japan Losartan Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Source
9.3.2.2.2.By Form
9.3.2.2.3.By Strength
9.3.2.2.4.By Distribution Channel
9.3.2.2.5.By Application
9.3.2.2.6.By End-User
9.3.3.India Losartan Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Source
9.3.3.2.2.By Form
9.3.3.2.3.By Strength
9.3.3.2.4.By Distribution Channel
9.3.3.2.5.By Application
9.3.3.2.6.By End-User
9.3.4.Australia Losartan Market Outlook
9.3.4.1.Market Size & Forecast
9.3.4.1.1.By Value
9.3.4.2.Market Share & Forecast
9.3.4.2.1.By Source
9.3.4.2.2.By Form
9.3.4.2.3.By Strength
9.3.4.2.4.By Distribution Channel
9.3.4.2.5.By Application
9.3.4.2.6.By End-User
9.3.5.South Korea Losartan Market Outlook
9.3.5.1.Market Size & Forecast
9.3.5.1.1.By Value
9.3.5.2.Market Share & Forecast
9.3.5.2.1.By Source
9.3.5.2.2.By Form
9.3.5.2.3.By Strength
9.3.5.2.4.By Distribution Channel
9.3.5.2.5.By Application
9.3.5.2.6.By End-User
9.3.6.Hong Kong Losartan Market Outlook
9.3.6.1.Market Size & Forecast
9.3.6.1.1.By Value
9.3.6.2.Market Share & Forecast
9.3.6.2.1.By Source
9.3.6.2.2.By Form
9.3.6.2.3.By Strength
9.3.6.2.4.By Distribution Channel
9.3.6.2.5.By Application
9.3.6.2.6.By End-User
9.3.7.Philippines Losartan Market Outlook
9.3.7.1.Market Size & Forecast
9.3.7.1.1.By Value
9.3.7.2.Market Share & Forecast
9.3.7.2.1.By Source
9.3.7.2.2.By Form
9.3.7.2.3.By Strength
9.3.7.2.4.By Distribution Channel
9.3.7.2.5.By Application
9.3.7.2.6.By End-User
9.3.8.Malaysia Losartan Market Outlook
9.3.8.1.Market Size & Forecast
9.3.8.1.1.By Value
9.3.8.2.Market Share & Forecast
9.3.8.2.1.By Source
9.3.8.2.2.By Form
9.3.8.2.3.By Strength
9.3.8.2.4.By Distribution Channel
9.3.8.2.5.By Application
9.3.8.2.6.By End-User
9.3.9.Indonesia Losartan Market Outlook
9.3.9.1.Market Size & Forecast
9.3.9.1.1.By Value
9.3.9.2.Market Share & Forecast
9.3.9.2.1.By Source
9.3.9.2.2.By Form
9.3.9.2.3.By Strength
9.3.9.2.4.By Distribution Channel
9.3.9.2.5.By Application
9.3.9.2.6.By End-User
9.3.10.Vietnam Losartan Market Outlook
9.3.10.1.Market Size & Forecast
9.3.10.1.1.By Value
9.3.10.2.Market Share & Forecast
9.3.10.2.1.By Source
9.3.10.2.2.By Form
9.3.10.2.3.By Strength
9.3.10.2.4.By Distribution Channel
9.3.10.2.5.By Application
9.3.10.2.6.By End-User
9.3.11.Thailand Losartan Market Outlook
9.3.11.1.Market Size & Forecast
9.3.11.1.1.By Value
9.3.11.2.Market Share & Forecast
9.3.11.2.1.By Source
9.3.11.2.2.By Form
9.3.11.2.3.By Strength
9.3.11.2.4.By Distribution Channel
9.3.11.2.5.By Application
9.3.11.2.6.By End-User
10.South America Losartan Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Source
10.2.2.By Form
10.2.3.By Strength
10.2.4.By Distribution Channel
10.2.5.By Application
10.2.6.By End-User
10.2.7.By Country
10.3.South America: Country Analysis
10.3.1.Brazil Losartan Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Source
10.3.1.2.2.By Form
10.3.1.2.3.By Strength
10.3.1.2.4.By Distribution Channel
10.3.1.2.5.By Application
10.3.1.2.6.By End-User
10.3.2.Argentina Losartan Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Source
10.3.2.2.2.By Form
10.3.2.2.3.By Strength
10.3.2.2.4.By Distribution Channel
10.3.2.2.5.By Application
10.3.2.2.6.By End-User
10.3.3.Colombia Losartan Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Source
10.3.3.2.2.By Form
10.3.3.2.3.By Strength
10.3.3.2.4.By Distribution Channel
10.3.3.2.5.By Application
10.3.3.2.6.By End-User
10.3.4.Chile Losartan Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.By Source
10.3.4.2.2.By Form
10.3.4.2.3.By Strength
10.3.4.2.4.By Distribution Channel
10.3.4.2.5.By Application
10.3.4.2.6.By End-User
11.Middle East and Africa Losartan Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Source
11.2.2.By Form
11.2.3.By Strength
11.2.4.By Distribution Channel
11.2.5.By Application
11.2.6.By End-User
11.2.7.By Country
11.3.MEA: Country Analysis
11.3.1.South Africa Losartan Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Source
11.3.1.2.2.By Form
11.3.1.2.3.By Strength
11.3.1.2.4.By Distribution Channel
11.3.1.2.5.By Application
11.3.1.2.6.By End-User
11.3.2.Saudi Arabia Losartan Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Source
11.3.2.2.2.By Form
11.3.2.2.3.By Strength
11.3.2.2.4.By Distribution Channel
11.3.2.2.5.By Application
11.3.2.2.6.By End-User
11.3.3.UAE Losartan Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Source
11.3.3.2.2.By Form
11.3.3.2.3.By Strength
11.3.3.2.4.By Distribution Channel
11.3.3.2.5.By Application
11.3.3.2.6.By End-User
11.3.4.Turkey Losartan Market Outlook
11.3.4.1.Market Size & Forecast
11.3.4.1.1.By Value
11.3.4.2.Market Share & Forecast
11.3.4.2.1.By Source
11.3.4.2.2.By Form
11.3.4.2.3.By Strength
11.3.4.2.4.By Distribution Channel
11.3.4.2.5.By Application
11.3.4.2.6.By End-User
11.3.5.Nigeria Losartan Market Outlook
11.3.5.1.Market Size & Forecast
11.3.5.1.1.By Value
11.3.5.2.Market Share & Forecast
11.3.5.2.1.By Source
11.3.5.2.2.By Form
11.3.5.2.3.By Strength
11.3.5.2.4.By Distribution Channel
11.3.5.2.5.By Application
11.3.5.2.6.By End-User
11.3.6.Kenya Losartan Market Outlook
11.3.6.1.Market Size & Forecast
11.3.6.1.1.By Value
11.3.6.2.Market Share & Forecast
11.3.6.2.1.By Source
11.3.6.2.2.By Form
11.3.6.2.3.By Strength
11.3.6.2.4.By Distribution Channel
11.3.6.2.5.By Application
11.3.6.2.6.By End-User
11.3.7.Algeria Losartan Market Outlook
11.3.7.1.Market Size & Forecast
11.3.7.1.1.By Value
11.3.7.2.Market Share & Forecast
11.3.7.2.1.By Source
11.3.7.2.2.By Form
11.3.7.2.3.By Strength
11.3.7.2.4.By Distribution Channel
11.3.7.2.5.By Application
11.3.7.2.6.By End-User
11.3.8.Ethiopia Losartan Market Outlook
11.3.8.1.Market Size & Forecast
11.3.8.1.1.By Value
11.3.8.2.Market Share & Forecast
11.3.8.2.1.By Source
11.3.8.2.2.By Form
11.3.8.2.3.By Strength
11.3.8.2.4.By Distribution Channel
11.3.8.2.5.By Application
11.3.8.2.6.By End-User
12.Market Dynamics
12.1.Drivers
12.2.Challenges
13.Market Trends & Developments
14.Competitive Landscape
14.1.Merck & Co. Inc.
14.2.Pfizer Inc.
14.3.Teva Pharmaceutical Industries Ltd.
14.4.Sanofi S.A.
14.5.Novartis International AG
14.6.Dr. Reddys Laboratories Ltd.
14.7.Sun Pharmaceuticals Industries Ltd.
14.8.Aurobindo Pharma Ltd.
14.9.Torrent Pharmaceutical Ltd.
14.10.Lupin Ltd.
14.11.Mylan N.V.
14.12.Ipca Laboratories Limited
14.13.Macleods Pharmaceuticals Limited
14.14.Abbott Laboratories
14.15.Cadila Healthcare Limited
15.Strategic Recommendations
16.About Us & Disclaimer

List Of Figures

Figure 1: Global Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Losartan Market Size, By Volume (USD Billion), 2016-2026F
Figure 3: Global Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 4: Global Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 5: Global Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 6: Global Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 7: Global Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 8: Global Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 9: Global Losartan Market Share, By Region (USD Billion), 2016-2026F
Figure 10: Global Losartan Market Share, By Company (USD Billion), 2016-2026F
Figure 11: Global Losartan Market Attractiveness Index, By Region, By Value, 2016-2026F
Figure 12: Global Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 13: North America Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 14: North America Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 15: North America Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 16: North America Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 17: North America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 18: North America Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 19: North America Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 20: North America Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 21: North America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 22: North America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 23: United States Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 24: United States Losartan Market Size, By Source, 2016-2026F
Figure 25: United States Losartan Market Size, By Form, 2016-2026F
Figure 26: United States Losartan Market Size, By Strength, 2016-2026F
Figure 27: United States Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 28: United States Losartan Market Share, By Application, 2016-2026F
Figure 29: United States Losartan Market Share, By End-User, 2016-2026F
Figure 30: Canada Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 31: Canada Losartan Market Size, By Source, 2016-2026F
Figure 32: Canada Losartan Market Size, By Form, 2016-2026F
Figure 33: Canada Losartan Market Size, By Strength, 2016-2026F
Figure 34: Canada Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 35: Canada Losartan Market Share, By Application, 2016-2026F
Figure 36: Canada Losartan Market Share, By End-User, 2016-2026F
Figure 37: Mexico Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 38: Mexico Losartan Market Size, By Source, 2016-2026F
Figure 39: Mexico Losartan Market Size, By Form, 2016-2026F
Figure 40: Mexico Losartan Market Size, By Strength, 2016-2026F
Figure 41: Mexico Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 42: Mexico Losartan Market Share, By Application, 2016-2026F
Figure 43: Mexico Losartan Market Share, By End-User, 2016-2026F
Figure 44: Europe Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 45: Europe Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 46: Europe Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 47: Europe Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 48: Europe Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 49: Europe Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 50: Europe Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 51: Europe Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 52: Europe Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 53: Europe Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 54: Germany Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Germany Losartan Market Size, By Source, 2016-2026F
Figure 56: Germany Losartan Market Size, By Form, 2016-2026F
Figure 57: Germany Losartan Market Size, By Strength, 2016-2026F
Figure 58: Germany Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 59: Germany Losartan Market Share, By Application, 2016-2026F
Figure 60: Germany Losartan Market Share, By End-User, 2016-2026F
Figure 61: France Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 62: France Losartan Market Size, By Source, 2016-2026F
Figure 63: France Losartan Market Size, By Form, 2016-2026F
Figure 64: France Losartan Market Size, By Strength, 2016-2026F
Figure 65: France Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 66: France Losartan Market Share, By Application, 2016-2026F
Figure 67: France Losartan Market Share, By End-User, 2016-2026F
Figure 68: United Kingdom Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 69: United Kingdom Losartan Market Size, By Source, 2016-2026F
Figure 70: United Kingdom Losartan Market Size, By Form, 2016-2026F
Figure 71: United Kingdom Losartan Market Size, By Strength, 2016-2026F
Figure 72: United Kingdom Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 73: United Kingdom Losartan Market Share, By Application, 2016-2026F
Figure 74: United Kingdom Losartan Market Share, By End-User, 2016-2026F
Figure 75: Italy Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 76: Italy Losartan Market Size, By Source, 2016-2026F
Figure 77: Italy Losartan Market Size, By Form, 2016-2026F
Figure 78: Italy Losartan Market Size, By Strength, 2016-2026F
Figure 79: Italy Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 80: Italy Losartan Market Share, By Application, 2016-2026F
Figure 81: Italy Losartan Market Share, By End-User, 2016-2026F
Figure 82: Spain Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 83: Spain Losartan Market Size, By Source, 2016-2026F
Figure 84: Spain Losartan Market Size, By Form, 2016-2026F
Figure 85: Spain Losartan Market Size, By Strength, 2016-2026F
Figure 86: Spain Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 87: Spain Losartan Market Share, By Application, 2016-2026F
Figure 88: Spain Losartan Market Share, By End-User, 2016-2026F
Figure 89: Russia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 90: Russia Losartan Market Size, By Source, 2016-2026F
Figure 91: Russia Losartan Market Size, By Form, 2016-2026F
Figure 92: Russia Losartan Market Size, By Strength, 2016-2026F
Figure 93: Russia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 94: Russia Losartan Market Share, By Application, 2016-2026F
Figure 95: Russia Losartan Market Share, By End-User, 2016-2026F
Figure 96: Poland Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 97: Poland Losartan Market Size, By Source, 2016-2026F
Figure 98: Poland Losartan Market Size, By Form, 2016-2026F
Figure 99: Poland Losartan Market Size, By Strength, 2016-2026F
Figure 100: Poland Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 101: Poland Losartan Market Share, By Application, 2016-2026F
Figure 102: Poland Losartan Market Share, By End-User, 2016-2026F
Figure 103: Asia-Pacific Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Asia-Pacific Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 105: Asia-Pacific Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 106: Asia-Pacific Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 107: Asia-Pacific Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 108: Asia-Pacific Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 109: Asia-Pacific Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 110: Asia-Pacific Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 111: Asia-Pacific Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 112: Asia-Pacific Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 113: China Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 114: China Losartan Market Size, By Source, 2016-2026F
Figure 115: China Losartan Market Size, By Form, 2016-2026F
Figure 116: China Losartan Market Size, By Strength, 2016-2026F
Figure 117: China Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 118: China Losartan Market Share, By Application, 2016-2026F
Figure 119: China Losartan Market Share, By End-User, 2016-2026F
Figure 120: Japan Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 121: Japan Losartan Market Size, By Source, 2016-2026F
Figure 122: Japan Losartan Market Size, By Form, 2016-2026F
Figure 123: Japan Losartan Market Size, By Strength, 2016-2026F
Figure 124: Japan Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 125: Japan Losartan Market Share, By Application, 2016-2026F
Figure 126: Japan Losartan Market Share, By End-User, 2016-2026F
Figure 127: India Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 128: India Losartan Market Size, By Source, 2016-2026F
Figure 129: India Losartan Market Size, By Form, 2016-2026F
Figure 130: India Losartan Market Size, By Strength, 2016-2026F
Figure 131: India Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 132: India Losartan Market Share, By Application, 2016-2026F
Figure 133: India Losartan Market Share, By End-User, 2016-2026F
Figure 134: Australia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 135: Australia Losartan Market Size, By Source, 2016-2026F
Figure 136: Australia Losartan Market Size, By Form, 2016-2026F
Figure 137: Australia Losartan Market Size, By Strength, 2016-2026F
Figure 138: Australia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 139: Australia Losartan Market Share, By Application, 2016-2026F
Figure 140: Australia Losartan Market Share, By End-User, 2016-2026F
Figure 141: South Korea Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 142: South Korea Losartan Market Size, By Source, 2016-2026F
Figure 143: South Korea Losartan Market Size, By Form, 2016-2026F
Figure 144: South Korea Losartan Market Size, By Strength, 2016-2026F
Figure 145: South Korea Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 146: South Korea Losartan Market Share, By Application, 2016-2026F
Figure 147: South Korea Losartan Market Share, By End-User, 2016-2026F
Figure 148: Hong Kong Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 149: Hong Kong Losartan Market Size, By Source, 2016-2026F
Figure 150: Hong Kong Losartan Market Size, By Form, 2016-2026F
Figure 151: Hong Kong Losartan Market Size, By Strength, 2016-2026F
Figure 152: Hong Kong Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 153: Hong Kong Losartan Market Share, By Application, 2016-2026F
Figure 154: Hong Kong Losartan Market Share, By End-User, 2016-2026F
Figure 155: Philippines Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 156: Philippines Losartan Market Size, By Source, 2016-2026F
Figure 157: Philippines Losartan Market Size, By Form, 2016-2026F
Figure 158: Philippines Losartan Market Size, By Strength, 2016-2026F
Figure 159: Philippines Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 160: Philippines Losartan Market Share, By Application, 2016-2026F
Figure 161: Philippines Losartan Market Share, By End-User, 2016-2026F
Figure 162: Malaysia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 163: Malaysia Losartan Market Size, By Source, 2016-2026F
Figure 164: Malaysia Losartan Market Size, By Form, 2016-2026F
Figure 165: Malaysia Losartan Market Size, By Strength, 2016-2026F
Figure 166: Malaysia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 167: Malaysia Losartan Market Share, By Application, 2016-2026F
Figure 168: Malaysia Losartan Market Share, By End-User, 2016-2026F
Figure 169: Indonesia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 170: Indonesia Losartan Market Size, By Source, 2016-2026F
Figure 171: Indonesia Losartan Market Size, By Form, 2016-2026F
Figure 172: Indonesia Losartan Market Size, By Strength, 2016-2026F
Figure 173: Indonesia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 174: Indonesia Losartan Market Share, By Application, 2016-2026F
Figure 175: Indonesia Losartan Market Share, By End-User, 2016-2026F
Figure 176: Vietnam Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 177: Vietnam Losartan Market Size, By Source, 2016-2026F
Figure 178: Vietnam Losartan Market Size, By Form, 2016-2026F
Figure 179: Vietnam Losartan Market Size, By Strength, 2016-2026F
Figure 180: Vietnam Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 181: Vietnam Losartan Market Share, By Application, 2016-2026F
Figure 182: Vietnam Losartan Market Share, By End-User, 2016-2026F
Figure 183: Thailand Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 184: Thailand Losartan Market Size, By Source, 2016-2026F
Figure 185: Thailand Losartan Market Size, By Form, 2016-2026F
Figure 186: Thailand Losartan Market Size, By Strength, 2016-2026F
Figure 187: Thailand Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 188: Thailand Losartan Market Share, By Application, 2016-2026F
Figure 189: Thailand Losartan Market Share, By End-User, 2016-2026F
Figure 190: South America Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 191: South America Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 192: South America Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 193: South America Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 194: South America Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 195: South America Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 196: South America Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 197: South America Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 198: South America Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 199: South America Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 200: Brazil Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 201: Brazil Losartan Market Size, By Source, 2016-2026F
Figure 202: Brazil Losartan Market Size, By Form, 2016-2026F
Figure 203: Brazil Losartan Market Size, By Strength, 2016-2026F
Figure 204: Brazil Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 205: Brazil Losartan Market Share, By Application, 2016-2026F
Figure 206: Brazil Losartan Market Share, By End-User, 2016-2026F
Figure 207: Argentina Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 208: Argentina Losartan Market Size, By Source, 2016-2026F
Figure 209: Argentina Losartan Market Size, By Form, 2016-2026F
Figure 210: Argentina Losartan Market Size, By Strength, 2016-2026F
Figure 211: Argentina Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 212: Argentina Losartan Market Share, By Application, 2016-2026F
Figure 213: Argentina Losartan Market Share, By End-User, 2016-2026F
Figure 214: Colombia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 215: Colombia Losartan Market Size, By Source, 2016-2026F
Figure 216: Colombia Losartan Market Size, By Form, 2016-2026F
Figure 217: Colombia Losartan Market Size, By Strength, 2016-2026F
Figure 218: Colombia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 219: Colombia Losartan Market Share, By Application, 2016-2026F
Figure 220: Colombia Losartan Market Share, By End-User, 2016-2026F
Figure 221: Chile Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 222: Chile Losartan Market Size, By Source, 2016-2026F
Figure 223: Chile Losartan Market Size, By Form, 2016-2026F
Figure 224: Chile Losartan Market Size, By Strength, 2016-2026F
Figure 225: Chile Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 226: Chile Losartan Market Share, By Application, 2016-2026F
Figure 227: Chile Losartan Market Share, By End-User, 2016-2026F
Figure 228: Middle East and Africa Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 229: Middle East and Africa Losartan Market Size, By Source (USD Billion), 2016-2026F
Figure 230: Middle East and Africa Losartan Market Share, By Form (USD Billion), 2016-2026F
Figure 231: Middle East and Africa Losartan Market Share, By Strength (USD Billion), 2016-2026F
Figure 232: Middle East and Africa Losartan Market Share, By Distribution Channel (USD Billion), 2016-2026F
Figure 233: Middle East and Africa Losartan Market Share, By Application (USD Billion), 2016-2026F
Figure 234: Middle East and Africa Losartan Market Share, By End-User (USD Billion), 2016-2026F
Figure 235: Middle East and Africa Losartan Market Share, By Country (USD Billion), 2016-2026F
Figure 236: Middle East and Africa Losartan Market Attractiveness Index, By Country, By Value, 2016-2026F
Figure 237: Middle East and Africa Losartan Market Attractiveness Index, By Source, By Value, 2016-2026F
Figure 238: South Africa Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 239: South Africa Losartan Market Size, By Source, 2016-2026F
Figure 240: South Africa Losartan Market Size, By Form, 2016-2026F
Figure 241: South Africa Losartan Market Size, By Strength, 2016-2026F
Figure 242: South Africa Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 243: South Africa Losartan Market Share, By Application, 2016-2026F
Figure 244: South Africa Losartan Market Share, By End-User, 2016-2026F
Figure 245: Saudi Arabia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 246: Saudi Arabia Losartan Market Size, By Source, 2016-2026F
Figure 247: Saudi Arabia Losartan Market Size, By Form, 2016-2026F
Figure 248: Saudi Arabia Losartan Market Size, By Strength, 2016-2026F
Figure 249: Saudi Arabia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 250: Saudi Arabia Losartan Market Share, By Application, 2016-2026F
Figure 251: Saudi Arabia Losartan Market Share, By End-User, 2016-2026F
Figure 252: UAE Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 253: UAE Losartan Market Size, By Source, 2016-2026F
Figure 254: UAE Losartan Market Size, By Form, 2016-2026F
Figure 255: UAE Losartan Market Size, By Strength, 2016-2026F
Figure 256: UAE Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 257: UAE Losartan Market Share, By Application, 2016-2026F
Figure 258: UAE Losartan Market Share, By End-User, 2016-2026F
Figure 259: Turkey Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 260: Turkey Losartan Market Size, By Source, 2016-2026F
Figure 261: Turkey Losartan Market Size, By Form, 2016-2026F
Figure 262: Turkey Losartan Market Size, By Strength, 2016-2026F
Figure 263: Turkey Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 264: Turkey Losartan Market Share, By Application, 2016-2026F
Figure 265: Turkey Losartan Market Share, By End-User, 2016-2026F
Figure 266: Nigeria Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 267: Nigeria Losartan Market Size, By Source, 2016-2026F
Figure 268: Nigeria Losartan Market Size, By Form, 2016-2026F
Figure 269: Nigeria Losartan Market Size, By Strength, 2016-2026F
Figure 270: Nigeria Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 271: Nigeria Losartan Market Share, By Application, 2016-2026F
Figure 272: Nigeria Losartan Market Share, By End-User, 2016-2026F
Figure 273: Kenya Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 274: Kenya Losartan Market Size, By Source, 2016-2026F
Figure 275: Kenya Losartan Market Size, By Form, 2016-2026F
Figure 276: Kenya Losartan Market Size, By Strength, 2016-2026F
Figure 277: Kenya Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 278: Kenya Losartan Market Share, By Application, 2016-2026F
Figure 279: Kenya Losartan Market Share, By End-User, 2016-2026F
Figure 280: Algeria Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 281: Algeria Losartan Market Size, By Source, 2016-2026F
Figure 282: Algeria Losartan Market Size, By Form, 2016-2026F
Figure 283: Algeria Losartan Market Size, By Strength, 2016-2026F
Figure 284: Algeria Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 285: Algeria Losartan Market Share, By Application, 2016-2026F
Figure 286: Algeria Losartan Market Share, By End-User, 2016-2026F
Figure 287: Ethiopia Losartan Market Size, By Value (USD Billion), 2016-2026F
Figure 288: Ethiopia Losartan Market Size, By Source, 2016-2026F
Figure 289: Ethiopia Losartan Market Size, By Form, 2016-2026F
Figure 290: Ethiopia Losartan Market Size, By Strength, 2016-2026F
Figure 291: Ethiopia Losartan Market Size, By Distribution Channel, 2016-2026F
Figure 292: Ethiopia Losartan Market Share, By Application, 2016-2026F
Figure 293: Ethiopia Losartan Market Share, By End-User, 2016-2026F

Global Medical Imaging Market (2021 Edition) – Analysis By Product (X-Ray, Ultrasound, MRI, CT Scan, Nuclear Imaging), End-User, Application, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)

Executive Global Medical Imaging Market was valued at USD 39.94 Billion in the year 2020. Medical Imaging refers to use of different imaging modalities to get visual representations of interior

USD 2400 View Report

Global Psychedelic Drugs Market (2021 Edition) – Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)

Executive The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected

USD 2200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available